They may suggest ways to save on Rybelsus, or they may want to discuss alternative medication options that would suit your needs
Capehorn M, Ghani Y, Hindsberger C, Johansen P, Jdar E (May 2020) Once-Weekly Semaglutide reduces HbA1c and body weight in patients with type 2 diabetes regardless of background common OAD: a Subgroup Analysis from SUSTAIN 24 and 10
Side effects may be fewer
That's why our program includes long-term maintenance planning and some patients choose to continue a lower maintenance dose for ongoing support
FH tirzepatide users, meanwhile, lost an average 13% of their body weight and an average 30 pounds
HSA/FSA eligibility and no insurance requirement further reduce costs, making sustained therapy affordable for most patients